LIVE QUOTE
Henry Schein, Inc. HSIC
Healthcare · Medical - Distribution · NASDAQ
$80.03
Market Cap$8.0B
P/E Ratio14.0
Beta0.82
Employees25,000

Investment Thesis

would occur if competitive dynamics shift significantly or if regulatory pressures increase substantially.

Competitive Moat

primarily derived from scale economies and intangible assets, including brand recognition and regulatory compliance expertise. With over 25,000 employees and a global distribution network, the company benefits from significant cost advantages, allowing it to negotiate better terms with suppliers and maintain competitive pricing. This advantage is durable over the next 5-10 years, although competitive threats from emerging digital health platforms and aggressive consolidation among local distributors could challenge its market position.

Growth Engine

Future revenue growth for HSIC is expected to stem from both organic growth and strategic acquisitions. The total addressable market (TAM) for dental and medical products is projected to expand significantly, driven by technological advancements and increasing healthcare expenditures. HSIC is actively pursuing geographic expansion, particularly in underpenetrated markets, and is enhancing its product offerings with innovative technology solutions, cementing its competitive advantage. The company is gaining market share, particularly in the digital solutions space, fortifying its growth trajectory.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research HSIC
Robinhood
$0 commission trades
Trade HSIC
Webull
Extended-hours, options, charts
Trade HSIC
TradingView
Advanced charts & screeners
Chart HSIC
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-06-09, HSIC has a P/E ratio of N/A, which suggests that it may not be generating positive earnings currently or is in a transition phase. Without a market cap provided, it's difficult to assess its valuation relative to the sector, but potential investors should consider these factors along with market conditions.
HSIC does not currently pay a dividend, as there is no information on a dividend yield provided.
HSIC operates in the Healthcare sector, specifically within the Medical - Distribution industry.
The market cap for HSIC is not provided in the available data, making it impossible to classify its size within the market cap categories.
HSIC's competitors in the medical distribution industry include companies like McKesson Corporation and Cardinal Health, which also provide a range of healthcare products and services.
FAQ generated 2026-06-09

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms